Commercial partnership for prototype development established.
Device proof-of-principle and feasibility completed.
Affordability and budget impact studies (UCT Health Economics).
GIFT patent granted SA (2016/03606).
Cost effectiveness study (UCT Health Economics).
Monoclonal antibody development.
GIFT patent granted EU (14809984.9).
GIFT v1.0 field ready prototype.
Clinical evaluation of GIFT v1.0.
GIFT v2.0 field ready prototype.
Clinical evaluation of GIFT v2.0.
Licensure trial of GIFT v2.0.
SAHPRA and CE-mark application.